Type:

Other

Description:

Access to the article is free, however registration and sign-in are required: The evolution of drug resistance in bacteria depends on a rapid mutation rate. However, drug resistance mutations frequently incur a cost to the microbe, usually a reduced growth rate. Unfortunately, this cost cannot be exploited because those crafty microbes usually develop compensatory mutations, which offset the growth disadvantage while maintaining drug resistance. In a Perspective, Bull and Levin discuss new findings (Björkman et al.) showing that different compensatory mutations evolve depending on whether pathogenic bacteria are grown in culture or in an animal host. They caution that care should be taken when trying to extrapolate in vitro findings about bacterial drug resistance to in vivo situations.

Subjects:

    Education Levels:

      Keywords:

      Microbial culture methods,oai:nsdl.org:2200/20110722031037968T,NSDL_SetSpec_BEN,in vitro bacterial cultures,compensatory mutations,in vivo bacterial cultures,drug resistance mutations,antimicrobial drugs,revertants,NSDL

      Language:

      English

      Access Privileges:

      Public - Available to anyone

      License Deed:

      Creative Commons Attribution Non-Commercial Share Alike

      Collections:

      None
      This resource has not yet been aligned.
      Curriki Rating
      'NR' - This resource has not been rated
      NR
      'NR' - This resource has not been rated

      This resource has not yet been reviewed.

      Not Rated Yet.

      Non-profit Tax ID # 203478467